UPDATE: Jefferies Cuts Target to $9 on VIVUS

Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.

Jefferies lowers its target $3 to $9 on Underperform-rated VIVUS (NASDAQ: VVUS) on takeaways from FDA Cardiovascular Safety Panel. Jefferies notes, "In spite of an unfavorable FDA panel vote recommending combined pre- and post-approval CV safety analyses even for obesity drugs without a theoreticalrisk of CV harm, after-market VVUS stock price indications still reflect strong optimism around approval. We remain cautious on the bull argument for several reasons outlined below and see a significant risk that Qnexa is subject to additional CV risk evaluation prior to approval."VVUS closed at $21.28 a share yesterday.

Crypto Whales Are Loading Up — Are You?

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!